The Nutshell

» ecology, cancer and clinical trials

Daily News Roundup

Most Recent

The Centers for Medicare and Medicaid Services propose covering the test with Medicare. 

0 Comments

The approval of the Roundup ingredient follows an extensive debate amidst conflicting evidence over the health effects of the world’s most popular weed killer. 

0 Comments

image: New CAR T-Cell Therapy Shows Promise in Trial for Leukemia

New CAR T-Cell Therapy Shows Promise in Trial for Leukemia

By | November 21, 2017

The immunotherapy, which targets CD22 on cancer cells rather than CD19, might prove useful in patients for whom previous T-cell treatments were unsuccessful. 

0 Comments

image: Man Receives First In Vivo Gene-Editing Therapy

Man Receives First In Vivo Gene-Editing Therapy

By | November 15, 2017

The 44-year-old patient has Hunter syndrome, which doctors hope to treat using zinc finger nucleases.

0 Comments

image: Cancer Researcher, Former AACR President Dies

Cancer Researcher, Former AACR President Dies

By | November 13, 2017

Donald Coffey, a longtime professor at Johns Hopkins University, discovered the nuclear matrix within cells and its role in DNA replication.

0 Comments

The report provides evidence that goes against concerns that Monsanto’s popular herbicide, Roundup, is carcinogenic. 

8 Comments

image: Equivocal Findings of Alzheimer’s Trial Using Young Blood

Equivocal Findings of Alzheimer’s Trial Using Young Blood

By | November 6, 2017

A team of Stanford University researchers say that administering young people’s blood plasma to Alzheimer’s patients could improve cognitive function, but the results have been criticized.

0 Comments

If approved, patisiran will be the first RNAi therapeutic on the market. 

0 Comments

image: <em>Oncotarget</em> Journal Cut from Medline

Oncotarget Journal Cut from Medline

By | October 26, 2017

New papers from a cancer journal once named as a possibly predatory publication will no longer appear in the widely used research database.

0 Comments

image: FDA Approves Second CAR T-Cell Therapy

FDA Approves Second CAR T-Cell Therapy

By | October 19, 2017

The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 

0 Comments

Popular Now

  1. Can Young Stem Cells Make Older People Stronger?
  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Two Dozen House Republicans Do an About-Face on Tuition Tax
  4. CRISPR to Debut in Clinical Trials